BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 16572402)

  • 21. Second malignant neoplasms following chemoreduction with carboplatin, etoposide, and vincristine in 245 patients with intraocular retinoblastoma.
    Turaka K; Shields CL; Meadows AT; Leahey A
    Pediatr Blood Cancer; 2012 Jul; 59(1):121-5. PubMed ID: 21826785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The success of primary chemotherapy for group D heritable retinoblastoma.
    Cohen VM; Kingston J; Hungerford JL
    Br J Ophthalmol; 2009 Jul; 93(7):887-90. PubMed ID: 18703556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Radiotherapy in the multimodality treatment of retinoblastomas in children].
    Goldobenko GV; Durnov LA; Lobanov GV; Liutova NA; Belkina BM
    Med Radiol (Mosk); 1985 Dec; 30(12):3-7. PubMed ID: 4079688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current treatment of retinoblastoma. 153 children treated between 1995 and 1998].
    Desjardins L; Levy C; Lumbroso L; Doz F; Schlienger P; Validire P; Asselain B; Bours D; Zucker JM
    J Fr Ophtalmol; 2000 May; 23(5):475-81. PubMed ID: 10844307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of overt extraocular retinoblastoma.
    Chantada G; Fandiño A; Casak S; Manzitti J; Raslawski E; Schvartzman E
    Med Pediatr Oncol; 2003 Mar; 40(3):158-61. PubMed ID: 12518344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New tumours in non-enucleated eyes of bilateral retinoblastoma patients.
    Roysarkar TK; Biswas J; Gopal L
    Indian J Ophthalmol; 1994 Mar; 42(1):19-22. PubMed ID: 7927625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of pediatric retinoblastoma treated with ICEV regimen: A single-center study.
    Buaboonnam J; Narkbunnam N; Vathana N; Takpradit C; Phuakpet K; Pongtanakul B; Tongsai S; Atchaneeyasakul LO; Sanpakit K
    Pediatr Hematol Oncol; 2019 Mar; 36(2):73-81. PubMed ID: 30983466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trilateral retinoblastoma.
    Meadows A
    Med Pediatr Oncol; 1986; 14(6):323-6. PubMed ID: 3784984
    [No Abstract]   [Full Text] [Related]  

  • 29. Trilateral retinoblastoma: is the location of the intracranial tumor important?
    Paulino AC
    Cancer; 1999 Jul; 86(1):135-41. PubMed ID: 10391573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy in patients with retinoblastoma.
    Hathirat P; Kunavisarut S; Chuansumrit A; Pochanukul L; Simaroj P; Isarangkura P
    J Med Assoc Thai; 1993 Oct; 76 Suppl 2():85-91. PubMed ID: 7823011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The treatment of retinoblastoma with four-drug regimen including cisplatin, etoposide, vincristine, and cyclophosphamide.
    Varan A; Kiratli H; Aydın B; Tarlan B; Poyraz CB; Akyüz C; Büyükpamukçu M
    Pediatr Hematol Oncol; 2012 Sep; 29(6):529-37. PubMed ID: 22759219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus-associated lymphoma in a child undergoing an autologous stem cell rescue.
    Heath JA; Broxson EH; Dole MG; Filippa DA; George D; Lyden D; Dunkel IJ
    J Pediatr Hematol Oncol; 2002 Feb; 24(2):160-3. PubMed ID: 11998794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intracranial fibrosarcoma fifteen years after radiotherapy in bilateral retinoblastomas: effect of combined chemotherapy with cisplatin and VP-16].
    Mizuno M; Yoshida J; Shimosawa S; Kuchiwaki H
    No Shinkei Geka; 1989 Jul; 17(7):653-7. PubMed ID: 2812266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
    Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
    Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prognosis and treatment of retinoblastoma. 105 cases treated at the Curie Institute].
    Haye C; Desjardins L; Elmaleh C; Schlienger P; Zucker JM; Laurent M
    Ophtalmologie; 1989; 3(3):183-6. PubMed ID: 2641106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinoblastoma in the state of Oklahoma: a clinicopathologic review.
    Scott MH; Richard JM
    J Okla State Med Assoc; 1993 Mar; 86(3):111-8. PubMed ID: 8445457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baseline central nervous system magnetic resonance imaging in early detection of trilateral retinoblastoma: pitfalls in the diagnosis of pineal gland lesions.
    De Ioris MA; Valente P; Randisi F; Buzzonetti L; Carai A; Cozza R; Del Bufalo F; Romanzo A; Angioni A; Cacchione A; Bernardi B; Mastronuzzi A
    Anticancer Res; 2014 Dec; 34(12):7449-54. PubMed ID: 25503186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant chemotherapy with vincristine, doxorubicin, and cyclophosphamide in the treatment of postenucleation high risk retinoblastoma.
    Mustafa MM; Jamshed A; Khafaga Y; Mourad WA; Al-Mesfer S; Kofide A; El-Husseiny G; Gray A
    J Pediatr Hematol Oncol; 1999; 21(5):364-9. PubMed ID: 10524448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma).
    Shields CL; Meadows AT; Shields JA; Carvalho C; Smith AF
    Arch Ophthalmol; 2001 Sep; 119(9):1269-72. PubMed ID: 11545631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trilateral retinoblastoma with pituitary-hypothalamic dysfunction.
    Dai S; Dimaras H; Héon E; Budning A; Doyle J; Halliday W; Drake J; Gallie BL; Chan HS
    Ophthalmic Genet; 2008 Sep; 29(3):120-5. PubMed ID: 18766991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.